Fagron - 股票

Fagron 权益回报率 2024

Fagron 权益回报率

0.15

股票代码

FAGR.BR

ISIN

BE0003874915

WKN

A0M103

在2024年,Fagron的股本回报率(ROE)为0.15,较上一年的0.17 ROE增长了-11.6%

Fagron Aktienanalyse

Fagron在做什么?

Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands. The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels. Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia. Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals. Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations). The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets. The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics. The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation. Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered. Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron ist eines der beliebtesten Unternehmen auf Eulerpool.com.

权益回报率的详细信息

Fagron的股本回报率(ROE)解密

Fagron的股本回报率(ROE)是一项基本的指标,用于评估公司相对于自有资本的盈利能力。ROE通过将净利润除以股东的股权来计算,展示了公司从股东投资中获取收益的效率。较高的ROE代表着增加的效率和盈利能力。

年度比较

对Fagron的ROE进行年度比较分析有助于追踪盈利趋势和财务表现。ROE的上升表明了盈利能力和为股东创造价值的增加,而ROE的下降则可能表明了盈利或者资本管理方面的问题。

对投资的影响

Fagron的ROE对评估公司的盈利能力、效率和投资吸引力的投资者来说是至关重要的。强大的ROE显示出公司将股权投资转化为盈利的能力,从而增加了其对潜在和现有投资者的吸引力。

对ROE波动的解读

Fagron的ROE的变化可能源于净利润、股权或两者的波动。这些波动被用来评估管理效率、财务策略及其相关的风险和机会,并帮助投资者做出明智的决策。

关于Fagron股票的常见问题

Fagron今年的股本回报率(ROE)有多高?

Fagron今年的ROE为0.15 undefined。

Fagron的股权回报率(ROE)与去年相比有何变化?

与去年相比,Fagron的ROE已经下降了-11.6%。

Fagron的高ROE(股本回报率)对投资者有什么影响?

一个高ROE表明Fagron获得了良好的资本回报,并成功地将其投资变现。对投资者来说,这是一个积极的指标。

Fagron的投资者,低ROE(股权回报率)会有什么影响?

一个较低的ROE可能表明Fagron在成功地将其投资变现方面面临困难,这可能对投资者来说是一个负面的信号。

Fagron的权益回报率(ROE)变化会对公司产生什么影响?

ROE(股东权益回报率)的变动Fagron可能是衡量公司财务表现的指标,并显示该公司与同行业其他公司相比有多成功。

如何计算Fagron的ROE(股本回报率)?

ROE(股本回报率)的计算方法是将公司的利润除以总股本。公式为:ROE = 利润 / 总股本。

Fagron的股本回报率(ROE)受哪些因素影响?

影响Fagron的股权回报率(ROE)的一些因素包括资本利用效率,公司的盈利能力和融资结构等。

可以采取哪些战略措施来提高ROE(股本回报率)?

为了提高的股本回报率(ROE),可以采取诸如削减成本、提高销售额、提高使用股本的效率以及在融资结构中进行更改等措施。重要的是,公司需要对其财务状况进行深入审查,以确定最佳的战略措施以提高股本回报率(ROE)。

Fagron支付多少股息?

在过去的12个月中,Fagron支付了0.25 EUR 的股息。这相当于大约1.4 %的股息收益率。在未来的12个月内,Fagron预计将支付0.28 EUR的股息。

Fagron的股息收益率有多高?

Fagron当前的股息收益率为1.4 %。

Fagron什么时候支付股息?

Fagron按季度支付股息。这些股息将在, , , 月份分发。

Fagron的股息有多安全?

Fagron 在过去0年里每年都支付了股息。

Fagron的股息有多高?

预计未来12个月的股息将达到0.28 EUR。这相当于1.59 %的股息收益率。

Fagron位于哪个行业?

Fagron 被分配到“健康”板块。

Wann musste ich die Aktien von Fagron kaufen, um die vorherige Dividende zu erhalten?

要获得Fagron在支付的0.3 EUR的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Fagron最后一次支付股息是什么时候?

上一次股息发放日期为。

Fagron在2023年的股息是多少?

在2023年,Fagron 分配了0.2 EUR作为股息。

Fagron 的股息是以哪种货币支付的?

Fagron的股息将以EUR的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Fagron

我们对Fagron 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Fagron 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: